- Case Report
- Open Access
Urachal carcinoma presenting with chronic mucusuria: a case report
© Efthimiou et al; licensee BioMed Central Ltd. 2008
- Received: 15 October 2008
- Accepted: 30 October 2008
- Published: 30 October 2008
Urachal adenocarcinoma is a rare tumor and represents 0.17–0.34% of all bladder tumors. It has an insidious course and variable clinical presentation. We present a case report of a 58 year old white male with an urachal cyst who suffered irritative voiding symptoms and long term mucusuria, since childhood. After surgical removal of the cyst with a partial cystectomy a mucus adenocarcinoma was diagnosed histologically.
The patient after a negative for metastatic disease screen underwent a completion radical cystectomy with pelvic lymph node clearance. Clinicians should have a high degree of suspicion for these rare tumors.
- Lower Urinary Tract Symptom
- Radical Cystectomy
- Pelvic Lymph Node Dissection
- Partial Cystectomy
Adenocarcinoma of the urachus arises from the urachal remnant. It is a rare and devastating disease, representing 0.17–0.34% of all bladder tumors [1, 2]. It is believed that arises from malignant transformation of columnar or glandular metaplastic epithelium. Clinically the distinction of urachal carcinoma from other bladder adenocarcinomas may be difficult especially if the tumor is locally extensive. Histological types include mucinous, enteric, unspecified, signet ring-cell, and mixed variants . In this case report we present a 58 year old white male with a long lasting history of mucusuria, recurrent bacteriuria and lower urinary tract symptoms which finally revealed urachal adenocarcinoma. Also a short review of the literature is presented.
Most cases of urachal adenocarcinomas occur in the fifth and sixth decade of life. Clinical presentation varies. Hematuria is encountered in more that two thirds of cases. Less common symptoms are mucusuria, lower urinary tract symptoms and a palpable suprapubic mass [4, 5]. Mucusuria presents in a 25% of the cases and merits special attention as it may be overlooked for an extremely long time before the correct diagnosis. The most common reason is confusion with lower urinary tract infections such as urethritis and chronic prostatitis.
If after a trial of antibiotic therapy symptoms do not resolve, a full urologic workup with cystoscopy and abdominal ultrasound or CT scan is indicated. CT appearance is of a large mixed solid and cystic lesion with the bulk of the tumor outside the bladder. Extravesical spread is common. In relation to the urinary bladder wall urachal carcinomas may be intramucosal, intramuscular or supravesival, (behind the anterior abdominal wall in the midline) . Tumor calcification is based on mucus production that is encountered in 72%. When present it suggests a urachal adenocarcinoma and it is usually located at the edge of the tumor and it is patchy rather than continuous [2, 7].
Treatment consists of open radical or partial cystectomy with pelvic lymph node dissection, and excision of the umbilicus and the urachal ligament [1, 2]. Laparoscopic partial cystectomy with lymphadenectomy has been reported as an alternative treatment but long term follow up is required in order to determine the oncologic effect of this treatment . In a recent study from Mayo clinic, staging with TNM system was the main predictor of outcome after surgery for urachal adenocarcinoma . Also negative margin status has been identified as an important factor for long term-survival and adequate local treatment is of paramount value [9, 10]. Prognosis does not appear to be significantly influenced by histology and grade of the tumor. Metastatic disease has a poor response to chemotherapy but some tumors may respond to cisplatin based regimens. Overall survival for all stages is 62 months with a 34% of the patients still alive after 5 years.
Misdiagnosis of urachal carcinoma is still a reality. Accurate diagnosis necessitates a degree of suspicion and appropriate imaging studies. Appropriate local treatment is the key for improved survival.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Wilson TG, Pritchett TR, Lieskovsky G, Warner NE, Skinner DG: Primary adenocarcinoma of bladder. Urology. 1991, 38: 223-6. 10.1016/S0090-4295(91)80349-C.View ArticlePubMedGoogle Scholar
- Sheldon C, Clayman R, Gonzalez R, Williams R, Fraley E: Malignant urachal lesions. J Urol. 1984, 131: 1-8.PubMedGoogle Scholar
- Ayala A, Tamboli P: Urachal carcinoma. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Edited by: Eble J, Sauter G, Epstein J, Sesterhenn I. 2004, IARC Press, 131-132.Google Scholar
- Johnson DE, Hodge GB, Abdul-Karim FW, Ayala AG: Urachal carcinoma. Urology. 1985, 26: 218-221. 10.1016/0090-4295(85)90112-8.View ArticlePubMedGoogle Scholar
- Grignon DJ, Ro JY, Ayala AG, Johnson DE, Ordonez NG: Primary adenocarcinoma of the bladder: a clinicopathological analysis o 72 cases. Cancer. 1991, 67: 2165-72. 10.1002/1097-0142(19910415)67:8<2165::AID-CNCR2820670827>3.0.CO;2-M.View ArticlePubMedGoogle Scholar
- Brick S, Friedman A, Pollack H, Frishman E, Radecki P, Siegelboum M, Mitchell D, Lev-Toaff A, Caroline D: Urachal carcinomas: CT findings. Radiol. 1988, 169: 377-381.View ArticleGoogle Scholar
- Thali-Schwab CM, Woodward PJ, Wagner BJ: Computed tomographic appearance of urachal adenocarcinomas: review of 25 cases. Eur Radiol. 2005, 15: 79-84. 10.1007/s00330-004-2408-z.View ArticlePubMedGoogle Scholar
- Thyavihally YB, Tongaonkar HB: Outcomes after laparoscopic partial cystectomy and bilateral pelvic lymph adenectomy in urachal adenocarcinoma of the bladder [abstract 684]. J Urol (Suppl). 2008, 4: 240.View ArticleGoogle Scholar
- Molina J, Quevedo J, Furth A, Richardson RL, Zinke H, Burch PA: Predictors of survival from Urachal cancer: A Mayo Clinic study of 49 cases. Cancer. 2007, 110: 2434-2440. 10.1002/cncr.23070.View ArticlePubMedGoogle Scholar
- Siefker-Radtke A, Gee J, Shen Y, Wen S, Daliani D, Millikan RE, Pisters LL: Multimodality management of urachal carcinoma: The M.D. Anderson Centre experience. J Urol. 2003, 169: 1295-8. 10.1097/01.ju.0000054646.49381.01.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.